Last Updated on March 1, 2024
Following guidelines are intended to help the industry and other applicants to meet the regulatory requirements related to the Quality Assurance and Import/Export of therapeutic goods. DRAP in collaboration with the Drug Control Organization of all federating units is enforcing the implementation and has regulatory oversight to ensure that the drug products being manufactured, imported, distributed, and sold, meet quality requirements and applicable regulations.
1. Manufacturing
2. Quality
![](https://i0.wp.com/www.dra.gov.pk/wp-content/uploads/2022/02/Guideline-Icon.png?resize=134%2C134&ssl=1)
Guidelines on Recalls and Rapid Alerts of Defective Therapeutic Goods
English ( 658 KB – PDF)
3. Supply Chain
4. Import and Export of Therapeutic Goods
![](https://i0.wp.com/www.dra.gov.pk/wp-content/uploads/2022/02/Guideline-Icon.png?resize=134%2C134&ssl=1)
Guidelines on Import and Export of Therapeutic Goods
English ( 609 KB – PDF)
![](https://i0.wp.com/www.dra.gov.pk/wp-content/uploads/2022/02/Guideline-Icon.png?resize=134%2C134&ssl=1)
User Manual / Guide for Online Import Export Software (OIES)
English ( 724 KB – PDF)